US2018051341A1PendingUtilityA1
Method for Reducing Sequencing Errors Caused by DNA Fragmentation
Est. expiryAug 17, 2036(~10.1 yrs left)· nominal 20-yr term from priority
C12Q 1/6806C12Y 302/02023C12Y 207/07007C12Y 605/01001C12Q 2600/156C12Q 1/6827C12Q 1/6874C12Q 1/6886C12Y 301/21002
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein, among other things, is a method for reducing sequencing errors caused by mechanical DNA fragmentation. In some embodiments, this method may comprise: (a) obtaining a DNA sample; (b) mechanically fragmenting the DNA sample to produce a template; (c) treating the fragmented DNA with a plurality of DNA repair enzymes; and (d) obtaining a sequence of the fragmented DNA. The treatment step (c) reduces the number of fragmentation induced errors.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for reducing sequencing errors caused by mechanical DNA fragmentation, comprising:
(a) obtaining a DNA sample; (b) mechanically fragmenting the DNA sample to produce a template; (c) treating the fragmented DNA with a plurality of DNA repair enzymes; and (d) obtaining a sequence of the fragmented DNA, wherein step (c) reduces the number of fragmentation induced errors.
2 . The method of claim 1 , wherein step (b) is done by acoustic shearing.
3 . The method of claim 1 , wherein the treating is done by treating the template with enzymes that include at least one DNA glycosylase, an AP endonuclease, a DNA polymerase and a ligase.
4 . The method of claim 3 , wherein the enzymes are in a mixture.
5 . The method of claim 3 , wherein the at least one DNA glycosylase comprises oxoguanine glycosylase (OGG) or formamidopyrimidine-DNA glycosylase (FPG).
6 . The method of claim 1 , wherein step (d) comprises amplifying the template.
7 . The method of claim 1 , wherein step (d) comprises circularlizing the template.
8 . The method of claim 1 , further comprising analyzing sequence reads to identify a sequence variation.
9 . The method of claim 1 , wherein the DNA sample made from a clinical sample.
10 . A method for detecting damaged DNA in a sample, comprising:
preparing a sequencing library from the damaged DNA; sequencing the sequencing library to obtain a plurality of first Watson end sequence reads (R1s) and plurality of second complementary Crick sequence reads (R2s); for a selected locus, identifying those R1s and R2s that have a sequence abnormality; and detecting an imbalance between the number of R1s that have a sequence abnormality and the number of R2s that have a complementary sequence abnormality at the same position.
11 . The method of claim 10 , wherein the damaged DNA is from a clinical sample.
12 . The method of claim 11 , wherein the clinical sample is a formalin fixed paraffin embedded (FFPE) sample.
13 . The method of claim 10 , wherein the damaged DNA is fragmented.
14 . The method of claim 13 , wherein the damaged DNA is fragmented by acoustic shearing.
15 . The method of claim 10 , wherein the sequence abnormality is a G to T transversion.
16 . The method of claim 10 , further comprising eliminating sequence reads, or sequence abnormalities, from further analysis if they are associated with an imbalance.Join the waitlist — get patent alerts
Track US2018051341A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.